Go here to tell your members of Congress to reject PHARMA’s push to change the donut hole deal. https://www.nrln.org/SE.html#/77
In President Trump’s and Congress’ Bipartisan Budget Act of 2018 deal in February there was a provision to further reduce the Medicare Part D “donut hole” in 2019, a year earlier than previously scheduled. Beginning next year, Part D enrollees will pay 25% of the cost of all their prescription drugs from the time they enter the donut hole until they reach catastrophic coverage. As part of the budget agreement, drug corporations are responsible for giving a 70% discount on drugs in the donut hole starting next year. However, PhRMA is lobbying to use the opioid bill to only pay 63% of costs in the Part D donut hole instead of the 70% they agreed to and was passed by Congress. This would result in a $4 billion windfall profit for the drug industry at the expense of patients. Pharmaceutical companies in the S&P 1500 earn an average net profit margin of 16%, compared with an average of about 7% for all companies in the index, according to S&P Capital IQ.
Please send the NRLN’s sample letter, with your personal comments added, to tell your U.S. Representative and Senators to keep their promise to further reduce the donut hole in 2019.